Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.

NCT00261391

Conditions: Arteriovenous Malformations, Cardiovascular Abnormalities, Cardiovascular Diseases, +8 more
Locations: Childrens Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

NCT00044902

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial

NCT00262444

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University Hospital Ghent Ghent, Belgium

View Trial Details

Completed

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

NCT00146211

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +23 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic Arizona Scottsdale, Arizona, United States

University of California San Diego La Jolla, California, United States

UCLA Medical Center Los Angeles, California, United States

View all 41 locations

View Trial Details

Completed

RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

NCT00307593

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +27 more
Locations: Hôpital Cochin Paris, France

View Trial Details

Completed

R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas

NCT00558220

Conditions: Diffuse Large B-Cell Lymphoma., Follicular Lymphoma Grade III, Hemic and Lymphatic Diseases, +11 more
Locations: University Hospital Brno-Bohunice Brno, Czechia

Hospital Chomutov Chomutov, Czechia

Hospital České Budějovice České Budějovice, Czechia

University Hospital Hradec Králové Hradec Králové, Czechia

View Trial Details

Completed

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

NCT00556127

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy

Ospedale Regionale, Divisione di Oncologia, Aosta, Italy

Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy

Osp. degli Infermi Biella, Italy

View all 14 locations

View Trial Details

Completed

Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children

NCT00552825

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Hematologic Diseases, +17 more
Locations: Sheba Medical CenterPediatric pulmonary unit, Pulmonary function laboratory Ramat Gan, Israel

View Trial Details

Completed

Treatment of Disseminated High Grade Lymphoma

NCT00536393

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Clinique Victor Hugo Le Mans, France

View Trial Details

Completed

Treatment of Localized Low Grade Lymphomas

NCT00536458

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Regional university hospital Besançon, France

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions